Crossmark

Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

Crossref DOI link: https://doi.org/10.1038/s41409-026-02823-2

Published Online: 2026-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Swoboda, Ryszard https://orcid.org/0000-0002-5897-3919
Ferhat, Allain-Thibeault

Blaise, Didier https://orcid.org/0000-0002-5684-9447
Koc, Mariya

Raiola, Anna Maria

Busca, Alessandro https://orcid.org/0000-0001-5361-5613
Pavlu, Jiri

Bramanti, Stefania https://orcid.org/0000-0002-4117-7991
Itälä-Remes, Maija

Colorado, Mercedes

Vydra, Jan https://orcid.org/0000-0002-4274-3895
Kulagin, Alexander https://orcid.org/0000-0002-9589-4136
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Sanz, Jaime https://orcid.org/0000-0001-6934-4619
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
License Information

Text and Data Mining valid from 2026-03-25

Version of Record valid from 2026-03-25
More Information

Article History

Received: 27 October 2025

Revised: 29 January 2026

Accepted: 3 March 2026

First Online: 25 March 2026

Competing interests

: The authors declare no competing interests.

: All methods were performed in accordance with the relevant guidelines and regulations. The scientific boards of the ALWP of the EBMT approved this study. Informed consent was obtained from all subjects.

Document is current

Any future updates will be listed below